Compare companies
Put any US companies we track side by side — SEC-sourced financials, ratios, forensic scores, and our Quality Score. Add up to four. No market price, no paywall.
AYTU BIOPHARMA, INC
| Metric | AYTU BIOPHARMA, INC AYTUHealthcare |
|---|---|
| Quality Score | 67 / 100 |
| Revenue (latest) | $66M |
| Net income (latest) | −$14M |
| Operating margin | −11.8% |
| Net margin | −20.4% |
| Return on equity | −71.5% |
| Return on assets | −10.9% |
| Return on capital (ROCE) | −12.8% |
| Debt / equity | — |
| Revenue growth (YoY) | 1.8% |
| Altman Z″ (distress) | — |
| Accruals / assets | −9.4% |
Latest reported figures from each company's own SEC filings (XBRL) plus our derived scores. Blank where a line item isn't cleanly tagged — never estimated. Descriptive factors, not advice. Open a company for its full multi-year history.